A detailed history of Syntax Research, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Syntax Research, Inc. holds 88 shares of TMO stock, worth $47,528. This represents 0.04% of its overall portfolio holdings.

Number of Shares
88
Previous 88 -0.0%
Holding current value
$47,528
Previous $46.7 Million 9.5%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$431.41 - $532.94 $3,451 - $4,263
-8 Reduced 8.33%
88 $46.7 Million
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $47,835 - $55,143
96 New
96 $48.6 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $212B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Syntax Research, Inc. Portfolio

Follow Syntax Research, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntax Research, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Syntax Research, Inc. with notifications on news.